Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases ; volume:63 ; number:1 ; day:7 ; month:6 ; year:2023 ; pages:1-7 ; date:12.2023
Advances in rheumatology ; 63, Heft 1 (7.6.2023), 1-7, 12.2023
- Creator
-
Pombo-Suárez, Manuel
Seoane-Mato, Daniel
Díaz-González, Federico
Sánchez-Alonso, Fernando
Sánchez-Jareño, Marta
Cea-Calvo, Luis
Castrejón, Isabel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s42358-023-00296-1
- URN
-
urn:nbn:de:101:1-2023091614490121655865
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pombo-Suárez, Manuel
- Seoane-Mato, Daniel
- Díaz-González, Federico
- Sánchez-Alonso, Fernando
- Sánchez-Jareño, Marta
- Cea-Calvo, Luis
- Castrejón, Isabel
- SpringerLink (Online service)
Other Objects (12)
Home storage of biological medications administered to patients with rheumatic diseases
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
Safety assessment and gastrointestinal retention of orally administered cerium oxide nanoparticles in rats
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Rheumatic disease
Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Increased age and the volume of intraoperative fluid administered predict urinary retention after elective inguinal herniorrhaphy
Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States
Home storage of biological medications administered to patients with rheumatic diseases
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
Safety assessment and gastrointestinal retention of orally administered cerium oxide nanoparticles in rats
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Rheumatic disease
Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Increased age and the volume of intraoperative fluid administered predict urinary retention after elective inguinal herniorrhaphy
Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States
Home storage of biological medications administered to patients with rheumatic diseases
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
Safety assessment and gastrointestinal retention of orally administered cerium oxide nanoparticles in rats
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Incidence of diabetic retinopathy in anti-tnf treated rheumatic disease patients with type 2 diabetes
Rheumatic disease
Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Increased age and the volume of intraoperative fluid administered predict urinary retention after elective inguinal herniorrhaphy